SCHEMBL10373566

SCHEMBL10373566

CCCCCC1=Nc2cccnc2Nc2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ DRD4 P21917 8/20 0.40
▸ DRD2 P14416 6/20 0.40
▸ NFKB1 P19838 1/20 0.38
▸ BLM P54132 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ HTR2A P28223 1/20 0.38
▸ AKT1 P31749 5/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ IDH1 O75874 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10373702 0.83 CHRM2 (0.36) CYP1A2SMN1; SMN2AKT1
SCHEMBL10372389 0.78 L3MBTL1 (0.40) DRD4DRD2
SCHEMBL10372444 0.74 CYP1A2 (0.49) CYP1A2SMN1; SMN2DRD4DRD2NFKB1
SCHEMBL10373751 0.74 CYP1A2 (0.46) CYP1A2SMN1; SMN2DRD4DRD2NFKB1
SCHEMBL2507893 0.72 CYP1A2 (0.50) CYP1A2SMN1; SMN2DRD4DRD2NFKB1
SCHEMBL10371143 0.72 LMNA (0.52) CYP1A2SMN1; SMN2DRD4DRD2NFKB1
SCHEMBL2507304 0.72 CYP1A2 (0.49) CYP1A2SMN1; SMN2DRD4DRD2NFKB1
SCHEMBL10371329 0.72 AKT1 (0.43) CYP1A2SMN1; SMN2DRD4DRD2AKT1
SCHEMBL10372365 0.71 CYP1A2 (0.45) CYP1A2SMN1; SMN2DRD4DRD2NFKB1
SCHEMBL10850442 0.71 LMNA (0.51) CYP1A2SMN1; SMN2DRD4DRD2NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0076017-B1 PHENYL SUBSTITUTED PYRIDO(1,4)BENZODIAZEPINES AND INTERMEDIATES THEREFOR A.H. ROBINS COMPANY, INCORPORATED (US) 1990-08-16 — — EP claimed
EP-0076017-A2 Phenyl substituted pyrido(1,4)benzodiazepines and intermediates therefor A.H. ROBINS COMPANY, INCORPORATED (US) 1983-04-06 — — EP claimed
EP-0076017-B1 PHENYL SUBSTITUTED PYRIDO(1,4)BENZODIAZEPINES AND INTERMEDIATES THEREFOR A.H. ROBINS COMPANY, INCORPORATED (US) 1990-08-16 — — EP disclosed
EP-0107261-B1 (2-((NITROPYRIDINYL)AMINO)PHENYL)ARYLMETHANONES AND SALTS, THEIR USE IN MEDICINE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THE PREPARATION OF (2-((AMINOPYRIDINYL)AMINO)PHENYL)ARYLMETHANONES AND PYRIDO(1,4)BENZODIAZEPINES A.H. ROBINS COMPANY, INCORPORATED (US) 1988-09-21 — — EP disclosed
US-4698430-A ANTIDEPRESSANT A. H. ROBINS COMPANY, INC. (US) 1987-10-06 — — US disclosed
US-4668675-A ANTIDEPRESSANTS A. H. ROBINS COMPANY, INCORPORATED (US) 1987-05-26 — — US disclosed
US-4628100-A ANTIDEPRESSANTS A. H. ROBINS COMPANY, INCORPORATED (US) 1986-12-09 — — US disclosed
US-4560510-A CONDENSATION OF AN AMINOCHLOROPYRIDINE WITH A ARYL(AMINOPHENYL)METHANONE WITH A BASE) A. H. ROBINS COMPANY, INCORPORATED (US) 1985-12-24 — — US disclosed
US-4556667-A (2-((AMINOPYRIDINYL)AMINO)PHENYL)ARYLMETHANONE INTERMEDIATES A. H. ROBINS COMPANY, INCORPORATED (US) 1985-12-03 — — US disclosed
EP-0157656-A2 Process and intermediates for the preparation of aryl substituded pyrido [1,4] benzodiazepines A.H. ROBINS COMPANY, INCORPORATED (US) 1985-10-09 — — EP disclosed
US-4518603-A ANTIDEPRESSANTS A. H. ROBINS COMPANY, INC. (US) 1985-05-21 — — US disclosed
US-4495183-A ANTIULCER AGENTS- GASTROLINTESTINAL DISORDERS A. H. ROBINS COMPANY, INCORPORATED (US) 1985-01-22 — — US disclosed
US-4480100-A CHEMICAL INTERMEDIATES FOR ANTIDEPRESSANTS A. H. ROBINS COMPANY, INC. (US) 1984-10-30 — — US disclosed
US-4447361-A ANTIDEPRESSANT A. H. ROBINS COMPANY, INC. (US) 1984-05-08 — — US disclosed
EP-0099614-A2 Nitro, amino and aroylamino-N-phenylpyridinamines and their use in a process for preparing pyrido(1,4)benzodiazapines A.H. ROBINS COMPANY, INCORPORATED (US) 1984-02-01 — — EP disclosed
EP-0076017-A2 Phenyl substituted pyrido(1,4)benzodiazepines and intermediates therefor A.H. ROBINS COMPANY, INCORPORATED (US) 1983-04-06 — — EP disclosed
Send feedback